108 related articles for article (PubMed ID: 7384752)
41. A human monoclonal antibody against varicella-zoster virus glycoprotein III.
Sugano T; Tomiyama T; Matsumoto Y; Sasaki S; Kimura T; Forghani B; Masuho Y
J Gen Virol; 1991 Sep; 72 ( Pt 9)():2065-73. PubMed ID: 1654371
[TBL] [Abstract][Full Text] [Related]
42. The reactions of monoclonal antibodies with structural proteins of mumps virus.
Orvell C
J Immunol; 1984 May; 132(5):2622-9. PubMed ID: 6201553
[TBL] [Abstract][Full Text] [Related]
43. Relatedness of glycoproteins expressed on the surface of simian herpes-virus virions and infected cells to specific HSV glycoproteins.
Eberle R; Black D; Hilliard JK
Arch Virol; 1989; 109(3-4):233-52. PubMed ID: 2482016
[TBL] [Abstract][Full Text] [Related]
44. Influenza virus-specific T cell-mediated cytotoxicity: integration of the virus antigen into the target cell membrane is essential for target cell formation.
Kurrle R; Wagner H; Röllinghoff M; Rott R
Eur J Immunol; 1979 Feb; 9(2):107-11. PubMed ID: 312203
[TBL] [Abstract][Full Text] [Related]
45. Efficient generation of respiratory syncytial virus (RSV)-neutralizing human MoAbs via human peripheral blood lymphocyte (hu-PBL)-SCID mice and scFv phage display libraries.
Nguyen H; Hay J; Mazzulli T; Gallinger S; Sandhu J; Teng Y; Hozumi N
Clin Exp Immunol; 2000 Oct; 122(1):85-93. PubMed ID: 11012623
[TBL] [Abstract][Full Text] [Related]
46. A comparison of the in vitro and in vivo activities of IgG and F(ab')2 fragments of a mixture of three monoclonal anti-Her-2 antibodies.
Spiridon CI; Guinn S; Vitetta ES
Clin Cancer Res; 2004 May; 10(10):3542-51. PubMed ID: 15161714
[TBL] [Abstract][Full Text] [Related]
47. Immunological relationships between mumps virus and parainfluenza viruses studied with monoclonal antibodies.
Orvell C; Rydbeck R; Löve A
J Gen Virol; 1986 Sep; 67 ( Pt 9)():1929-39. PubMed ID: 3018131
[TBL] [Abstract][Full Text] [Related]
48. Studies of the human lymphocyte receptor for heat-aggregated or antigen-complexed immunoglobulin.
Dickler HB
J Exp Med; 1974 Aug; 140(2):508-22. PubMed ID: 4603014
[TBL] [Abstract][Full Text] [Related]
49. Cytolytic mechanisms involved in non-MHC-restricted cytotoxicity in Chediak-Higashi syndrome.
Nakazawa T; Agematsu K; Yasui K; Onodera T; Inoue R; Kaneko H; Kondo N; Yamamoto M; Kayagaki N; Yagita H; Okumura K; Komiyama A
Clin Exp Immunol; 1999 Oct; 118(1):108-14. PubMed ID: 10540167
[TBL] [Abstract][Full Text] [Related]
50. Conversion of nonfusing mumps virus infections to fusing infections by selective proteolysis of the HN glycoprotein.
Merz DC; Wolinsky JS
Virology; 1983 Dec; 131(2):328-40. PubMed ID: 6362184
[TBL] [Abstract][Full Text] [Related]
51. Mechanisms of enhancement of Epstein-Barr virus-induced transformation of peripheral blood lymphocytes by a tumor promoter, TPA, with special reference to lowering of cytotoxicity of T cells.
Harada S; Katsuki T; Yamamoto H; Hinuma Y
Int J Cancer; 1981 May; 27(5):617-23. PubMed ID: 6270019
[TBL] [Abstract][Full Text] [Related]
52. Interaction of K lymphocytes with myeloma proteins of different IgG subclasses.
Spiegelberg HL; Perlmann H; Perlmann P
J Immunol; 1976 Nov; 117(5 Pt 1):1464-71. PubMed ID: 1002986
[TBL] [Abstract][Full Text] [Related]
53. Mechanisms of killing of measles virus-infected cells by human lymphocytes: interferon associated and unassociated cell-mediated cytotoxicity.
Casali P; Oldstone MB
Cell Immunol; 1982 Jul; 70(2):330-44. PubMed ID: 6181900
[No Abstract] [Full Text] [Related]
54. Cell-mediated cytotoxicity against measles virus in SSPE. II. Analysis of cytotoxic effector cells.
Kreth HW; Wiegand G
J Immunol; 1977 Jan; 118(1):296-301. PubMed ID: 830753
[TBL] [Abstract][Full Text] [Related]
55. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE
MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311
[TBL] [Abstract][Full Text] [Related]
56. 51Chromium-release microassay technique for cell-mediated immunity to mumps virus: correlation with humoral and delayed-type skin hypersensitivity responses.
Rola-Pleszczynski M; Vincent MM; Hensen SA; Walser J; Crawford M; Bellanti JA
J Infect Dis; 1976 Dec; 134(6):546-51. PubMed ID: 1003011
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
Neville ME; Hiserodt JC
J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
[TBL] [Abstract][Full Text] [Related]
58. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
Cesson V; Stirnemann K; Robert B; Luescher I; Filleron T; Corradin G; Mach JP; Donda A
Clin Cancer Res; 2006 Dec; 12(24):7422-30. PubMed ID: 17189415
[TBL] [Abstract][Full Text] [Related]
59. Mechanisms of lymphocyte-mediated cytotoxicity. I. The effects of anti-human lymphotoxin antisera on the cytolysis of allogeneic B cell lines by MLC-sensitized human lymphocytes in vitro.
Ware CF; Granger GA
J Immunol; 1981 May; 126(5):1919-26. PubMed ID: 6452481
[TBL] [Abstract][Full Text] [Related]
60. Demonstration of primary cytotoxic T cells in venous blood and cerebrospinal fluid of children with mumps meningitis.
Kreth HW; Kress L; Kress HG; Ott HF; Eckert G
J Immunol; 1982 Jun; 128(6):2411-5. PubMed ID: 6176633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
